JP2021534099A5 - - Google Patents
Info
- Publication number
- JP2021534099A5 JP2021534099A5 JP2021506624A JP2021506624A JP2021534099A5 JP 2021534099 A5 JP2021534099 A5 JP 2021534099A5 JP 2021506624 A JP2021506624 A JP 2021506624A JP 2021506624 A JP2021506624 A JP 2021506624A JP 2021534099 A5 JP2021534099 A5 JP 2021534099A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- perfluoro
- hydrogen
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004449A JP2024056694A (ja) | 2018-08-06 | 2024-01-16 | 神経変性疾患を治療するためのPpargc1a活性化剤としての2‐アリールベンゾイミダゾール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862714962P | 2018-08-06 | 2018-08-06 | |
| US62/714,962 | 2018-08-06 | ||
| PCT/US2019/045229 WO2020033359A1 (en) | 2018-08-06 | 2019-08-06 | 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004449A Division JP2024056694A (ja) | 2018-08-06 | 2024-01-16 | 神経変性疾患を治療するためのPpargc1a活性化剤としての2‐アリールベンゾイミダゾール |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534099A JP2021534099A (ja) | 2021-12-09 |
| JP2021534099A5 true JP2021534099A5 (cg-RX-API-DMAC7.html) | 2022-08-12 |
| JP7422737B2 JP7422737B2 (ja) | 2024-01-26 |
Family
ID=69413327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506624A Active JP7422737B2 (ja) | 2018-08-06 | 2019-08-06 | 神経変性疾患を治療するためのPpargc1a活性化剤としての2‐アリールベンゾイミダゾール |
| JP2024004449A Pending JP2024056694A (ja) | 2018-08-06 | 2024-01-16 | 神経変性疾患を治療するためのPpargc1a活性化剤としての2‐アリールベンゾイミダゾール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004449A Pending JP2024056694A (ja) | 2018-08-06 | 2024-01-16 | 神経変性疾患を治療するためのPpargc1a活性化剤としての2‐アリールベンゾイミダゾール |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US12195432B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3833344A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7422737B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210068399A (cg-RX-API-DMAC7.html) |
| CN (2) | CN119033775A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019319745B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021002165A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3108773A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL280664B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2021001456A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202101285YA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI904076B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020033359A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2830447T3 (es) | 2015-12-15 | 2021-06-03 | Univ Leland Stanford Junior | Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación |
| BR112021002165A2 (pt) | 2018-08-06 | 2021-05-04 | The Board Of Trustees Of The Leland Stanford Junior University | composto, composição farmacêutica, e, métodos para tratar uma doença neurodegenerativa e deficiência cognitiva associada ao envelhecimento e neuroinflamação |
| EP4118435A1 (en) * | 2020-03-13 | 2023-01-18 | Biorchestra Co., Ltd. | Diagnostic methods using pgc-1? expression |
| CN112933232A (zh) * | 2021-02-02 | 2021-06-11 | 袁玉佳 | PGC-1α激活TFEB介导的自噬在制备治疗急性肾损伤的药物中的应用 |
| CN118541152A (zh) * | 2021-11-02 | 2024-08-23 | 特朗奎斯治疗股份有限公司 | 具有循环髓样细胞炎性表型的受试者的选择和治疗 |
| US20250262189A1 (en) * | 2022-04-22 | 2025-08-21 | Rdiscovery, LLC | Treatment of diseases associated with reductive stress |
| CN120752039A (zh) * | 2022-11-18 | 2025-10-03 | 五条聪 | Zln-005和相关化合物的用途 |
| US20260199293A1 (en) * | 2022-12-02 | 2026-07-16 | Tranquis Therapeutics, Inc. | 2-Arylbenzimidazole Compounds for the Treatment of Hemoglobinopathies |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL275435A (cg-RX-API-DMAC7.html) * | 1961-03-01 | |||
| FR1569337A (cg-RX-API-DMAC7.html) * | 1968-06-18 | 1969-05-30 | ||
| US4038396A (en) | 1975-02-24 | 1977-07-26 | Merck & Co., Inc. | Anti-inflammatory oxazole[4,5-b]pyridines |
| GB1584296A (en) * | 1976-12-07 | 1981-02-11 | Kanebo Ltd | 2-substituted benzimidazole compounds |
| NZ234564A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | 1-substituted benzimidazoles and pharmaceutical compositions |
| DE3830060A1 (de) | 1988-09-03 | 1990-03-15 | Boehringer Mannheim Gmbh | 2-phenylbenzimidazole - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| US5552426A (en) | 1994-04-29 | 1996-09-03 | Eli Lilly And Company | Methods for treating a physiological disorder associated with β-amyloid peptide |
| JPH09169729A (ja) * | 1995-12-19 | 1997-06-30 | Green Cross Corp:The | 非ペプチド型インターロイキン8拮抗剤 |
| CA2258728C (en) * | 1996-06-19 | 2011-09-27 | Rhone Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| JP2000143635A (ja) * | 1998-06-10 | 2000-05-26 | Takeda Chem Ind Ltd | 血管新生阻害剤 |
| JP2000095767A (ja) * | 1998-09-28 | 2000-04-04 | Takeda Chem Ind Ltd | 性腺刺激ホルモン放出ホルモン拮抗剤 |
| TR200101239T2 (tr) * | 1998-11-03 | 2001-11-21 | Basf Aktiengesellschaft | İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları |
| JP2004515496A (ja) * | 2000-12-07 | 2004-05-27 | アストラゼネカ・アクチエボラーグ | ベンズイミダゾール治療剤 |
| DE10134775A1 (de) * | 2001-07-06 | 2003-01-30 | Schering Ag | 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
| SE0301371D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | New Compounds |
| WO2005112913A1 (en) | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
| BRPI0512239A (pt) | 2004-06-17 | 2008-02-19 | Wyeth Corp | processos para preparação de antagonistas de receptores de hormÈnios liberadores de gonatropina |
| WO2006122546A1 (de) | 2005-05-18 | 2006-11-23 | Forschungsverbund Berlin E.V. | Nicht-peptidische inhibitoren der akap-pka-wechselwirkung |
| CA2616512A1 (en) | 2005-07-28 | 2007-02-08 | Intervet International B.V. | Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof |
| US7345178B2 (en) | 2005-08-04 | 2008-03-18 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| WO2008059026A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| GB0807103D0 (en) | 2008-04-18 | 2008-05-21 | Univ Bradford The | Compounds |
| US8835648B2 (en) * | 2009-06-11 | 2014-09-16 | Siena Biotech S.P.A. | Hedgehog pathway antagonists and therapeutic applications thereof |
| WO2011047129A1 (en) | 2009-10-15 | 2011-04-21 | Southern Research Institute | Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |
| MX2012005248A (es) * | 2009-11-06 | 2012-06-14 | Univ Vanderbilt | Aril- y heteroaril-sulfonas como potenciadores alostericos de mglur4, composiciones y metodos de tratamiento de la disfuncion neurologica. |
| GB201009656D0 (en) * | 2010-06-09 | 2010-07-21 | Univ St Andrews | Carboxylation catalysts |
| JP5083393B2 (ja) | 2010-09-16 | 2012-11-28 | カシオ計算機株式会社 | 画像表示装置及びプログラム |
| EP2651405A2 (en) | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Casein kinase 1 (ck1 ) inhibitors |
| WO2012118935A1 (en) | 2011-03-03 | 2012-09-07 | Proteotech Inc | Compounds for the treatment of neurodegenerative diseases |
| CN104662018B (zh) | 2012-04-20 | 2017-10-24 | 阿迪维纳斯治疗有限公司 | 取代的杂双环化合物、组合物及其医疗应用 |
| WO2014037340A1 (de) * | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Verwendung substituierter 2-amidobenzimidazole, 2-amidobenzoxazole und 2-amidobenzothiazole oder deren salze als wirkstoffe gegen abiotischen pflanzenstress |
| KR101435496B1 (ko) | 2012-10-22 | 2014-08-28 | 한국과학기술연구원 | 미토콘드리아 기능 조절제로서의 벤즈이미다졸 유도체 |
| GB201302927D0 (en) * | 2013-02-20 | 2013-04-03 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| CN103113307B (zh) * | 2013-02-27 | 2015-08-05 | 南京大学 | 苯并咪唑类化合物及其应用 |
| US10022357B2 (en) | 2013-04-29 | 2018-07-17 | The General Hospital Corporation | Amyloid precursor protein MRNA blockers for treating Down syndrome and Alzheimer's disease |
| WO2016061190A1 (en) | 2014-10-14 | 2016-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method for treating neurodegenerative diseases |
| CN104873500A (zh) | 2015-04-29 | 2015-09-02 | 中国人民解放军第四军医大学 | 化合物zln005的用途 |
| EP3294715B1 (en) | 2015-05-11 | 2020-05-06 | Kancera AB | Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity |
| ES2830447T3 (es) * | 2015-12-15 | 2021-06-03 | Univ Leland Stanford Junior | Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación |
| CN108602812B (zh) | 2015-12-22 | 2021-11-02 | 坎塞拉有限公司 | 可用作哺乳动物组蛋白去乙酰化酶活性的抑制剂的双环异羟肟酸类化合物 |
| JP2018083799A (ja) | 2016-11-15 | 2018-05-31 | バイオエレクトロン テクノロジー コーポレイション | 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩 |
| BR112021002165A2 (pt) | 2018-08-06 | 2021-05-04 | The Board Of Trustees Of The Leland Stanford Junior University | composto, composição farmacêutica, e, métodos para tratar uma doença neurodegenerativa e deficiência cognitiva associada ao envelhecimento e neuroinflamação |
-
2019
- 2019-08-06 BR BR112021002165-5A patent/BR112021002165A2/pt not_active Application Discontinuation
- 2019-08-06 JP JP2021506624A patent/JP7422737B2/ja active Active
- 2019-08-06 CN CN202411199938.0A patent/CN119033775A/zh active Pending
- 2019-08-06 CN CN201980065941.4A patent/CN112805000A/zh active Pending
- 2019-08-06 IL IL280664A patent/IL280664B2/en unknown
- 2019-08-06 IL IL298535A patent/IL298535B2/en unknown
- 2019-08-06 CA CA3108773A patent/CA3108773A1/en active Pending
- 2019-08-06 IL IL307972A patent/IL307972A/en unknown
- 2019-08-06 TW TW108127925A patent/TWI904076B/zh active
- 2019-08-06 KR KR1020217006736A patent/KR20210068399A/ko not_active Ceased
- 2019-08-06 US US17/266,433 patent/US12195432B2/en active Active
- 2019-08-06 SG SG11202101285YA patent/SG11202101285YA/en unknown
- 2019-08-06 AU AU2019319745A patent/AU2019319745B2/en active Active
- 2019-08-06 MX MX2021001456A patent/MX2021001456A/es unknown
- 2019-08-06 WO PCT/US2019/045229 patent/WO2020033359A1/en not_active Ceased
- 2019-08-06 EP EP19845943.0A patent/EP3833344A4/en active Pending
-
2020
- 2020-05-29 US US16/888,040 patent/US10851066B2/en active Active
- 2020-10-13 US US17/068,985 patent/US11111217B2/en active Active
-
2021
- 2021-02-04 MX MX2023012694A patent/MX2023012694A/es unknown
-
2024
- 2024-01-16 JP JP2024004449A patent/JP2024056694A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5255983B2 (ja) | カルバペネム系抗生物質、組成物及び調製方法 | |
| JP2020507589A5 (cg-RX-API-DMAC7.html) | ||
| MXPA01006474A (es) | Derivados colquinol como agentes perjudiciales vasculares. | |
| WO2009039981A3 (en) | Use of (arg 8) vasopressin to treat eg s. pneumoniae infection | |
| JP2023512501A5 (cg-RX-API-DMAC7.html) | ||
| IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
| JP2022527556A5 (cg-RX-API-DMAC7.html) | ||
| TW201619142A (zh) | 利用替唑尼特(tizoxanide)、其類似物或鹽類之前驅藥的組成物及治療方法 | |
| AU2002359164A8 (en) | Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 | |
| WO2009033665A3 (en) | Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent | |
| IL187183A0 (en) | Pharmaceutical formulation of apomorphine for buccal administration | |
| WO2009033785A3 (en) | Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hiv infection | |
| WO1994020063A3 (en) | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof | |
| UA98462C2 (ru) | Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig | |
| JP2015521617A5 (cg-RX-API-DMAC7.html) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| EP2849738A1 (en) | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions | |
| SE9901573D0 (sv) | New compounds | |
| AU2016246802A1 (en) | Boron-containing small molecules as antiprotozoal agents | |
| JP5297815B2 (ja) | 医薬組成物 | |
| DE2964903D1 (en) | 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them | |
| JP2003522786A5 (cg-RX-API-DMAC7.html) | ||
| JP2004026678A (ja) | 2型糖尿病治療剤 | |
| EP2909216B1 (en) | Compositions and methods for improving glucose uptake | |
| EP3931205A1 (en) | Antibacterial peptides and methods of use |